This study aimed to investigate the impact of GDNF on DAT expression and distribution, as well as its potential mechanism in a PD mouse model treated with 1-methyl-4-phenyl-1,2,3, 6-Tetrahydro-Pyridine (MPTP) and a PD cell model exposed to MPP + . This evidence concerns the gene SLC6A3 and Parkinson disease.